iomethin: diagnostic aid in determining malignant melanoma; RN given refers to parent cpd; structure
ID Source | ID |
---|---|
PubMed CID | 28212 |
CHEMBL ID | 2110614 |
SCHEMBL ID | 11883123 |
MeSH ID | M0041068 |
Synonym |
---|
n-(7-iodoquinolin-4-yl)-n',n'-dimethylpropane-1,3-diamine |
nm-113 |
1,3-propanediamine, n-(7-iodo-4-quinolinyl)-n',n'-dimethyl- |
unii-82l4s53hzf |
17127-81-0 |
iomethin |
4-(3-dimethylaminopropylamino)-7-iodoquinoline |
82l4s53hzf , |
SCHEMBL11883123 |
CHEMBL2110614 |
1,3-propanediamine, n3-(7-iodo-4-quinolinyl)-n1,n1-dimethyl- |
quinoline, 4-((3-(dimethylamino)propyl)amino)-7-iodo- |
4-((3-(dimethylamino)propyl)amino)-7-iodoquinoline |
1,3-propanediamine, n'-(7-iodo-4-quinolinyl)-n,n-dimethyl- |
DTXSID90169054 |
7-iodo-4-(3-dimethylaminopropylamino)quinoline |
Q27269337 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |